RecruitingNCT05400824

Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION


Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment

2,000 participants

Start Date

May 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.


Eligibility

Min Age: 18 YearsMax Age: 67 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood, DNA, feces, urine, hair and skin microbiota collection for people with cardiovascular diseases, general population, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood, DNA, feces, urine, hair and skin microbiota collection

See above


Locations(1)

Centre Hospitalier Universitaire de La Réunion

La Réunion, Saint-Pierre, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05400824


Related Trials